Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Novartis AG Common Stock
(NY:
NVS
)
129.93
+2.73 (+2.15%)
Streaming Delayed Price
Updated: 11:14 AM EST, Nov 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
392,637
Open
128.81
Bid (Size)
129.88 (800)
Ask (Size)
129.92 (100)
Prev. Close
127.20
Today's Range
128.72 - 129.95
52wk Range
96.06 - 133.55
Shares Outstanding
N/A
Dividend Yield
3.07%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps
November 10, 2025
The artificial intelligence (AI) sector is currently navigating a period of unprecedented dynamism, characterized by explosive technological advancements, massive capital inflows, and a palpable...
Via
TokenRing AI
Topics
Artificial Intelligence
Novartis Opens New Manufacturing Facility In California In Bid To Increase US Presence
November 10, 2025
Via
Stocktwits
Performance
YTD
+33.8%
+33.8%
1 Month
+0.6%
+0.6%
3 Month
+9.6%
+9.6%
6 Month
+19.3%
+19.3%
1 Year
+23.0%
+23.0%
More News
Read More
AI Achieves Atomic Precision in Antibody Design: A New Era for Drug Discovery Dawns
November 05, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Intellectual Property
Earnings Scheduled For October 28, 2025
October 28, 2025
Via
Benzinga
Celcuity Eyeing Cancer Treatment Riddle. Stock Flys 534% This Year.
November 05, 2025
Via
Investor's Business Daily
AI Unleashes a New Era in Cell and Gene Therapy: A Quarter Century Update Reveals Transformative Potential
November 04, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Terns Pharmaceuticals' Leukemia Drug Seen As Potential Disruptor In CML Treatment Landscape, Analyst Upgrades
November 03, 2025
Via
Benzinga
iShares Core MSCI EAFE ETF (IEFA) Focuses on Developed Markets While Vanguard FTSE All-World ex-US ETF (VEU) Looks Globally
November 03, 2025
Via
The Motley Fool
Topics
ETFs
Trump Offers Help To 'Dilbert' Creator's Cancer Fight
November 03, 2025
Via
Benzinga
Topics
Government
The Vanguard FTSE Developed Markets ETF (VEA) Offers Broader Diversification Than the SPDR Portfolio Developed World ex-US ETF (SPDW)
November 02, 2025
Via
The Motley Fool
Topics
ETFs
Vanguard VEA ETF Boasts Broader Portfolio Than State Street's SPDR SPDW
November 02, 2025
Via
The Motley Fool
Topics
ETFs
AI Unleashes a New Era: Biopharma’s Accelerated Revolution and the Rise of TechBio
November 01, 2025
Via
TokenRing AI
Topics
Animal Testing
Artificial Intelligence
Economy
The AI Imperative: Why Rapid Upskilling is Non-Negotiable for Pharma’s Future
October 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
October 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Supply Chain
AI Revolutionizes Pharma R&D: A New Era of Accelerated Drug Discovery and Personalized Medicine
October 31, 2025
Via
TokenRing AI
Topics
Artificial Intelligence
Intellectual Property
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
October 31, 2025
Via
TokenRing AI
Topics
Animal Testing
Artificial Intelligence
Economy
Here's Why Avidity Biosciences Stock Soared This Week (There's More to the Deal Than You Might Think)
October 31, 2025
Via
The Motley Fool
Here's My Favorite Passive Income Investment
October 31, 2025
Via
The Motley Fool
Topics
ETFs
Is the Market Bullish or Bearish on Novartis AG?
October 29, 2025
Via
Benzinga
United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short
October 29, 2025
Via
Investor's Business Daily
Novartis Slips As Generics Champ At Heart-Failure Drug In Mixed Third Quarter
October 28, 2025
Via
Investor's Business Daily
Novartis Maintains Outlook Even As Generics Bite Into Profits
October 28, 2025
Via
Benzinga
'Merger Monday' Makes Comeback As US M&A Tops $80 Billion In 24 Hours
October 28, 2025
Via
Benzinga
Is It Too Late To Buy Avidity Stock After Novartis Deal?
October 28, 2025
Via
Talk Markets
Why Dyne Therapeutics Stock Crushed the Market on Monday
October 27, 2025
Via
The Motley Fool
Frequently Asked Questions
Is Novartis AG Common Stock publicly traded?
Yes, Novartis AG Common Stock is publicly traded.
What exchange does Novartis AG Common Stock trade on?
Novartis AG Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novartis AG Common Stock?
The ticker symbol for Novartis AG Common Stock is NVS on the New York Stock Exchange
What is the current price of Novartis AG Common Stock?
The current price of Novartis AG Common Stock is 129.93
When was Novartis AG Common Stock last traded?
The last trade of Novartis AG Common Stock was at 11/11/25 11:14 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.